CoChat

Desirable cell death during anticancer chemotherapy

Locher, Clara, Conforti, Rosa, Aymeric, Laetitia, Ma, Yuting, Yamazaki, Takahiro, Rusakiewicz, Sylvie, Tesnière, Antoine, Ghiringhelli, François, Apetoh, Lionel, Morel, Yannis, Girard, Jean‐Philippe, Kroemer, Guido, Zitvogel, Laurence · 2010 · Annals of the New York Academy of Sciences
Cited by 83

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

The concept of immunogenic chemotherapy that has recently emerged relies upon the capacity of a cytotoxic compound to trigger a cell‐death modality. This modality elicits cross‐priming by dendritic cells of tumor antigen‐specific T cells that will contribute to the tumoricidal activity of the compound and protect the host against relapse. In contrast, most anticancer drugs elicit nonimmunogenic apoptosis that is not accompanied with an immunizing property. This review will discuss some molecular and metabolic changes required at the level of the tumor that must engage key pathways at the level of the host for the induction of Tc1 polarized–protective T cell responses during chemotherapy. We will summarize the immune adjuvants that can boost the immunogenicity of cell death to augment the efficacy of chemotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1749-6632.2010.05763.x

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 83

Metadata

Authors
Locher, C., Conforti, R., Aymeric, L., Ma, Y., Yamazaki, T., Rusakiewicz, S., Tesnière, A., Ghiringhelli, F., Apetoh, L., Morel, Y., Girard, J., Kroemer, G., & Zitvogel, L.
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2010-10
Volume
1209
Issue
1
Pages
99-108
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W1592864174
Cited by
83
References
16
FWCI
4.92
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Desirable cell death during anticancer chemotherapy. https://app.cochat.ai/papers/10.1111/j.1749-6632.2010.05763.x
The paper
Locher, C., Conforti, R., Aymeric, L., Ma, Y., Yamazaki, T., Rusakiewicz, S., Tesnière, A., Ghiringhelli, F., Apetoh, L., Morel, Y., Girard, J., Kroemer, G., & Zitvogel, L. (2010). Desirable cell death during anticancer chemotherapy. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2010.05763.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.